Sheer size of Asian CBD market, higher growth rate than North America and Europe
China and other Asian countries to become world's main CBD products production hub
Technology and safety standards lower in Asia - opportunity for western technology and processes
Exceptional investment opportunities for early entrants, particularly in healthcare and cosmetics
South Korea legalises CBD oil for skin care
and is in talks to further ease restrictions in
Malaysia announced decision
to legalise medical marijuana.
Thailand announced decision
to legalise medical marijuana.
Sri Lanka set to launch first plantation
for domestic medical use.
China holds over half of 600 international
Cannabinoid patents, including methods of
administering the drug.
China produces half the world’s industrial
hemp and is poised to become the main
global supplier of CBD.
China holds over half of 600 international Cannabinoid patents, including methods of administering the drug.
China produces half the world’s industrial hemp and is poised to become the main global supplier of CBD.
Cannabis and hemp are both sources of the cannaboids CBD and THC
THC is the psychoactive compound famous for the cannabis high
Hemp contains CBD
and very little THC
CBD is valued for its non-psychoactive medical benefits
Common uses include anti-anxiety, anti-convulsant and pain relief
The local rules and regulations in approved provinces allow for the open development of hemp and CBD related products such as textile clothes, foods, medicines and health care products. As an example, in Yunnan Province, a company named Hanma Investment Group Co., Ltd. (HMI Group), which has obtained the “the approval of the R & D and production and sales of the terminal products of CBD” by the Drug Control Bureau of the Yunnan Provincial Public Security Bureau. This approval allowed it to use CBD as a raw material for terminal product development, production and marketing, and clarified the legal status of CBD as a “non-drug component, not included in drug control”. Moreover, the company in November of 2017 launched cosmetic and body care products with the brand “Cannaclear”, which was the first brand in China to be allowed to use hemp extract as cosmeceuticals.
According to New Frontier Data, Chinese hemp sales totalled $1.1 billion in 2017, approaching 1/3 of the $3.1 billion global market, with sales forecasted to grow to $1.5 billion (up 36%) by 2020. These forecasts are supported by increased sales of Chinese hemp totalling $1.2 billion in 2018, as the Economist reported. Another group, Hong Kong-based investment company Regent Pacific Group, forecasts the CBD market in China alone to be worth $15 billion by 2024, citing the beauty and wellness sector as the main driver.
Social media, such as WeChat, is a powerful means of initiating online purchases in Asia. Our proprietary technology is an Omni platform which utilises WeChat as it’s primary e-commerce channel. WeChat has 10.8 billion users and continues to expand rapidly. It is the fastest growing e-commerce platform in revenue terms. Asian consumers are the most digital savvy on the planet and WeChat offers them ease and convenience. So it’s not surprising the platform is expanding so rapidly